<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>52(4)</volume><submitter>Urban IA</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>This non-inferiority randomised clinical trial aimed to compare vertical bone gain (VBG), volumetric bone changes and incidence of complications after vertical ridge augmentation (VRA) using perforated titanium-reinforced dense-polytetrafluoroethylene (PTFE) mesh covered by a collagen membrane (CM) or used alone.&lt;h4>Materials and methods&lt;/h4>Thirty patients with vertical bone defects were randomly assigned to receive VRA with either PTFE + CM or PTFE alone. Meshes were removed after 9 months. Clinical assessments included complication rates, pseudo-periosteum type and bone density. VBG, effective regeneration rate and the need for additional augmentation were evaluated using CBCT reconstructions.&lt;h4>Results&lt;/h4>Non-inferiority of PTFE alone compared with PTFE + CM was not demonstrated for absolute and relative VBG (4.5 ± 2.1 mm vs. 4.1 ± 2.7 mm, 79.2% ± 16.6% vs. 85.8% ± 10.6%, respectively), effective regeneration rates (69.3% ± 17.9% vs. 72.3% ± 16.4%, respectively) or complication rates (6.7% in both groups). A higher incidence of type 1 pseudo-periosteum was observed in the PTFE + CM group.&lt;h4>Conclusion&lt;/h4>The non-inferiority of PTFE alone compared with PTFE + CM for absolute VBG was not established. However, both techniques led to comparable outcomes for VBG, complication rates and bone density. The higher incidence of type 1 pseudo-periosteum and lacking bone volume in the PTFE + CM group suggests that adding a collagen membrane may help prevent soft tissue ingrowth.&lt;h4>Trial registration&lt;/h4>Clinicaltrials.gov identification number: NCT04843488.</pubmed_abstract><journal>Journal of clinical periodontology</journal><pagination>575-588</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11949596</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of Collagen Membrane in Vertical Ridge Augmentation Using Ti-Reinforced PTFE Mesh: A Randomised Controlled Trial.</pubmed_title><pmcid>PMC11949596</pmcid><pubmed_authors>Serroni M</pubmed_authors><pubmed_authors>Saleh MHA</pubmed_authors><pubmed_authors>Barath Z</pubmed_authors><pubmed_authors>Forster A</pubmed_authors><pubmed_authors>Dias DR</pubmed_authors><pubmed_authors>Urban IA</pubmed_authors><pubmed_authors>Araujo TG</pubmed_authors><pubmed_authors>Cucchi A</pubmed_authors><pubmed_authors>Ravida A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Collagen Membrane in Vertical Ridge Augmentation Using Ti-Reinforced PTFE Mesh: A Randomised Controlled Trial.</name><description>&lt;h4>Aims&lt;/h4>This non-inferiority randomised clinical trial aimed to compare vertical bone gain (VBG), volumetric bone changes and incidence of complications after vertical ridge augmentation (VRA) using perforated titanium-reinforced dense-polytetrafluoroethylene (PTFE) mesh covered by a collagen membrane (CM) or used alone.&lt;h4>Materials and methods&lt;/h4>Thirty patients with vertical bone defects were randomly assigned to receive VRA with either PTFE + CM or PTFE alone. Meshes were removed after 9 months. Clinical assessments included complication rates, pseudo-periosteum type and bone density. VBG, effective regeneration rate and the need for additional augmentation were evaluated using CBCT reconstructions.&lt;h4>Results&lt;/h4>Non-inferiority of PTFE alone compared with PTFE + CM was not demonstrated for absolute and relative VBG (4.5 ± 2.1 mm vs. 4.1 ± 2.7 mm, 79.2% ± 16.6% vs. 85.8% ± 10.6%, respectively), effective regeneration rates (69.3% ± 17.9% vs. 72.3% ± 16.4%, respectively) or complication rates (6.7% in both groups). A higher incidence of type 1 pseudo-periosteum was observed in the PTFE + CM group.&lt;h4>Conclusion&lt;/h4>The non-inferiority of PTFE alone compared with PTFE + CM for absolute VBG was not established. However, both techniques led to comparable outcomes for VBG, complication rates and bone density. The higher incidence of type 1 pseudo-periosteum and lacking bone volume in the PTFE + CM group suggests that adding a collagen membrane may help prevent soft tissue ingrowth.&lt;h4>Trial registration&lt;/h4>Clinicaltrials.gov identification number: NCT04843488.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-02T21:12:38.903Z</modification><creation>2026-05-29T03:06:30.186Z</creation></dates><accession>S-EPMC11949596</accession><cross_references><pubmed>39953742</pubmed><doi>10.1111/jcpe.14129</doi></cross_references></HashMap>